Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAMPRENAVIR vs FOSAPREPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAMPRENAVIR vs FOSAPREPITANT: Safety Overview

Metric FOSAMPRENAVIR FOSAPREPITANT
Total FAERS Reports 460 487
Deaths Reported 31 154
Death Rate 6.7% 31.6%
Hospitalizations 91 264
Average Patient Age 45.3 yrs 49.6 yrs
% Female Patients 27.9% 83.0%
FDA Approval Date Apr 15, 2016 N/A
Manufacturer Sun Pharmaceutical Industries, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A